Bio-Rad Laboratories, Inc. Class B

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO.B and other ETFs, options, and stocks.

About BIO.B

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO.B Key Statistics

Market cap
9.76B
Market cap9.76B
Price-Earnings ratio
46.66
Price-Earnings ratio46.66
Dividend yield
Dividend yield
Average volume
26.95
Average volume26.95
High today
$387.39
High today$387.39
Low today
$387.39
Low today$387.39
Open price
$387.39
Open price$387.39
Volume
9.00
Volume9.00
52 Week high
$387.39
52 Week high$387.39
52 Week low
$244.54
52 Week low$244.54

Stock Snapshot

With a market cap of 9.76B, Bio-Rad Laboratories, Inc. Class B(BIO.B) trades at $387.39. The stock has a price-to-earnings ratio of 46.66.

On 2026-08-24, Bio-Rad Laboratories, Inc. Class B(BIO.B) stock traded between a low of $387.39 and a high of $387.39. Shares are currently priced at $387.39, which is 0.0% above the low and 0.0% below the high.

The Bio-Rad Laboratories, Inc. Class B(BIO.B)'s current trading volume is 9, compared to an average daily volume of 26.95.

In the last year, Bio-Rad Laboratories, Inc. Class B(BIO.B) shares hit a 52-week high of $387.39 and a 52-week low of $244.54.

In the last year, Bio-Rad Laboratories, Inc. Class B(BIO.B) shares hit a 52-week high of $387.39 and a 52-week low of $244.54.

BIO.B News

Simply Wall St 3d
Why Bio-Rad Laboratories Is Up 6.7% After Restructuring Move Amid Mixed Segment Trends

In recent weeks, Bio-Rad Laboratories reported continued growth in its digital PCR business, supported by strong instrument sales and contributions from the Sti...

Why Bio-Rad Laboratories Is Up 6.7% After Restructuring Move Amid Mixed Segment Trends

Analyst ratings

50%

of 6 ratings
Buy
33.3%
Hold
50%
Sell
16.7%

People also own

Based on the portfolios of people who own BIO.B. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.